Maria Hoeltzenbein

4.9k total citations · 1 hit paper
54 papers, 2.8k citations indexed

About

Maria Hoeltzenbein is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Genetics. According to data from OpenAlex, Maria Hoeltzenbein has authored 54 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Public Health, Environmental and Occupational Health, 20 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Maria Hoeltzenbein's work include Pregnancy and Medication Impact (20 papers), Pregnancy and preeclampsia studies (11 papers) and Genomic variations and chromosomal abnormalities (10 papers). Maria Hoeltzenbein is often cited by papers focused on Pregnancy and Medication Impact (20 papers), Pregnancy and preeclampsia studies (11 papers) and Genomic variations and chromosomal abnormalities (10 papers). Maria Hoeltzenbein collaborates with scholars based in Germany, United States and France. Maria Hoeltzenbein's co-authors include Christof Schaefer, Vera M. Kalscheuer, Hans‐Hilger Ropers, Corinna Weber‐Schoendorfer, Élisabeth Éléfant, Monika Østensen, Carina Gøtestam Skorpen, Corinna Menzel, José António Pereira da Silva and Catherine Nelson‐Piercy and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Maria Hoeltzenbein

50 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

2016 689 citations Maria Hoeltzenbein, Élisabeth Éléfant et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Hoeltzenbein Germany	23	926	899	794	722	420	54	2.8k
Philippe Jonveaux France	31	666 0.7×	2.1k 2.3×	1.6k 2.0×	308 0.4×	162 0.4×	134	4.1k
Peter Wieacker Germany	35	392 0.4×	2.4k 2.7×	1.6k 2.1×	194 0.3×	114 0.3×	141	3.8k
Yisrael Sidis United States	32	398 0.4×	2.1k 2.4×	568 0.7×	158 0.2×	211 0.5×	47	4.1k
Eamonn Sheridan United Kingdom	28	450 0.5×	1.2k 1.3×	776 1.0×	191 0.3×	310 0.7×	74	2.7k
Stephen R. Braddock United States	25	302 0.3×	525 0.6×	538 0.7×	238 0.3×	195 0.5×	71	1.7k
Giandomenico Palka Italy	31	330 0.4×	1.5k 1.7×	1.5k 1.9×	144 0.2×	306 0.7×	145	3.3k
Sally Ann Lynch Ireland	34	214 0.2×	1.6k 1.8×	1.4k 1.8×	150 0.2×	278 0.7×	146	3.7k
Gioacchino Scarano Italy	25	154 0.2×	1.2k 1.3×	838 1.1×	74 0.1×	189 0.5×	83	2.3k
William K. Rashbaum United States	22	160 0.2×	675 0.8×	108 0.1×	353 0.5×	185 0.4×	52	1.9k
Niels Græm Denmark	27	432 0.5×	1.1k 1.3×	662 0.8×	117 0.2×	129 0.3×	77	2.6k

Countries citing papers authored by Maria Hoeltzenbein

Since Specialization

Citations

This map shows the geographic impact of Maria Hoeltzenbein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Hoeltzenbein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Hoeltzenbein more than expected).

Fields of papers citing papers by Maria Hoeltzenbein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Hoeltzenbein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Hoeltzenbein. The network helps show where Maria Hoeltzenbein may publish in the future.

Co-authorship network of co-authors of Maria Hoeltzenbein

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Hoeltzenbein. A scholar is included among the top collaborators of Maria Hoeltzenbein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Hoeltzenbein. Maria Hoeltzenbein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoeltzenbein, Maria, et al.. (2024). Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohort. Scientific Reports. 14(1). 30585–30585.

Hoeltzenbein, Maria, et al.. (2023). Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide. Seizure. 107. 107–113. 12 indexed citations

Hoeltzenbein, Maria, et al.. (2023). Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: An observational study. Epilepsia. 65(1). 26–36. 4 indexed citations

Weber‐Schoendorfer, Corinna, Ursula Winterfeld, Georgios Eleftheriou, et al.. (2019). Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors. Journal of Hypertension. 38(1). 133–141. 18 indexed citations

Hoeltzenbein, Maria, et al.. (2019). #33 Lacosamide use during pregnancy – An evaluation of the German embryotox database. Reproductive Toxicology. 88. 143–144. 2 indexed citations

Hoeltzenbein, Maria, et al.. (2017). OP 27 Methyldopa during the first trimester and pregnancy outcome – A prospective observational cohort study. Pregnancy Hypertension. 9. 21–21.

Hoeltzenbein, Maria, et al.. (2013). Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity. PLoS ONE. 8(6). e66637–e66637. 23 indexed citations

Hoeltzenbein, Maria, Élisabeth Éléfant, Thierry Vial, et al.. (2012). Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. American Journal of Medical Genetics Part A. 158A(3). 588–596. 139 indexed citations

Chen, Wei, Reinhard Ullmann, Corinna Menzel, et al.. (2009). Breakpoint analysis of balanced chromosome rearrangements by next-generation paired-end sequencing. European Journal of Human Genetics. 18(5). 539–543. 50 indexed citations

10.

Tzschach, Andreas, Maria Hoeltzenbein, Kirsten Hoffmann, et al.. (2006). Heterotaxy and cardiac defect in a girl with chromosome translocation t(X;1)(q26;p13.1) and involvement of ZIC3. European Journal of Human Genetics. 14(12). 1317–1320. 14 indexed citations

11.

Tzschach, Andreas, Corinna Menzel, Vera M. Kalscheuer, et al.. (2006). Molecular cytogenetic analysis of a de novo interstitial deletion of 5q23.3q31.2 and its phenotypic consequences. American Journal of Medical Genetics Part A. 140A(5). 496–502. 10 indexed citations

12.

Weiss, Jayne S., Veena Theendakara, Gerard Tromp, et al.. (2004). Clinical Characteristics of 22 Families With Schnyder's Crystalline Corneal Dystrophy. Investigative Ophthalmology & Visual Science. 45(13). 1519–1519. 1 indexed citations

13.

Zühlke, Christine, Andreas Dalski, Korinna Straube, et al.. (2004). Extension of the mutation spectrum in Friedreich's ataxia: detection of an exon deletion and novel missense mutations. European Journal of Human Genetics. 12(11). 979–982. 33 indexed citations

14.

Theendakara, Veena, Gerard Tromp, Helena Kuivaniemi, et al.. (2004). Fine mapping of the Schnyder?s crystalline corneal dystrophy locus. Human Genetics. 114(6). 594–600. 16 indexed citations

15.

Ropers, Hans‐Hilger, Maria Hoeltzenbein, Vera M. Kalscheuer, et al.. (2003). Nonsyndromic X-linked mental retardation: where are the missing mutations?. Trends in Genetics. 19(6). 316–320. 46 indexed citations

16.

Shoichet, Sarah A., Kirsten Hoffmann, Corinna Menzel, et al.. (2003). Mutations in the ZNF41 Gene Are Associated with Cognitive Deficits: Identification of a New Candidate for X-Linked Mental Retardation. The American Journal of Human Genetics. 73(6). 1341–1354. 65 indexed citations

17.

Munier, Francis L., Béatrice E. Frueh, Philippe Othenin‐Girard, et al.. (2002). BIGH3 mutation spectrum in corneal dystrophies.. PubMed. 43(4). 949–54. 178 indexed citations

18.

Huehne, Kathrin, Vladimír Beneš, Christian T. Thiel, et al.. (2002). Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1. Human Mutation. 21(1). 100–100. 15 indexed citations

19.

Hoeltzenbein, Maria & F.M.S. Tomé. (2001). Oppenheim's Myatonia Congenita. Neuropediatrics. 32(2). 57–61. 1 indexed citations

20.

Schulz, Angela, Kirsten Timmermann, Maria Hoeltzenbein, et al.. (2000). Functional Characterization of the Molecular Defects Causing Nephrogenic Diabetes Insipidus in Eight Families¹. The Journal of Clinical Endocrinology & Metabolism. 85(4). 1703–1710. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact